These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27252563)

  • 41. Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.
    Akiyama MJ; Kaba F; Rosner Z; Alper H; Kopolow A; Litwin AH; Venters H; MacDonald R
    Public Health Rep; 2017; 132(1):41-47. PubMed ID: 28005477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers.
    Rattay T; Dumont IP; Heinzow HS; Hutton DW
    Gastroenterology; 2017 Dec; 153(6):1531-1543.e2. PubMed ID: 29074450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of treatment for hepatitis C virus infection by primary care providers.
    Arora S; Thornton K; Murata G; Deming P; Kalishman S; Dion D; Parish B; Burke T; Pak W; Dunkelberg J; Kistin M; Brown J; Jenkusky S; Komaromy M; Qualls C
    N Engl J Med; 2011 Jun; 364(23):2199-207. PubMed ID: 21631316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic hepatitis C in Western Canada: a survey of practice patterns among gastroenterologists in Alberta and British Columbia.
    Pai R; Ramji A; Lee SS; Wong WW; Yoshida EM
    Can J Gastroenterol Hepatol; 2014 Jan; 28(1):e1-4. PubMed ID: 24212914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of a brief educational program on knowledge and willingness to accept treatment among patients with hepatitis C at inner-city hospitals.
    Gupta K; Romney D; Briggs M; Benker K
    J Community Health; 2007 Aug; 32(4):221-30. PubMed ID: 17696047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Hepatitis C virus treatment cascade at an urban postincarceration transitions clinic.
    Hawks L; Norton BL; Cunningham CO; Fox AD
    J Viral Hepat; 2016 Jun; 23(6):473-8. PubMed ID: 26856967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Barriers and facilitators of linkage to HIV primary care in New York City.
    Bauman LJ; Braunstein S; Calderon Y; Chhabra R; Cutler B; Leider J; Rivera A; Sclafane J; Tsoi B; Watnick D
    J Acquir Immune Defic Syndr; 2013 Nov; 64 Suppl 1(0 1):S20-6. PubMed ID: 24126445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of hepatitis C infection in New York City, 2004.
    Bornschlegel K; Berger M; Garg RK; Punsalang A; McKinney CM; Gwynn RC; Thorpe LE
    J Urban Health; 2009 Nov; 86(6):909-17. PubMed ID: 19672718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic.
    Malespin M; Harris C; Kanar O; Jackman K; Smotherman C; Johnston A; Ferm J; de Melo SW; Scolapio JS; Nelson DR; Cotler SJ
    Ann Hepatol; 2019; 18(2):304-309. PubMed ID: 31053544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Provider assessment of eligibility for hepatitis C treatment in HIV-infected homeless and marginally housed persons.
    Thompson VV; Ragland KE; Hall CS; Morgan M; Bangsberg DR
    AIDS; 2005 Oct; 19 Suppl 3():S208-14. PubMed ID: 16251820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Barriers to prenatal care among low-income women in New York City.
    Kalmuss D; Fennelly K
    Fam Plann Perspect; 1990; 22(5):215-8, 231. PubMed ID: 2272380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary Care Perspectives on Hepatitis C Virus Screening, Diagnosis and Linking Patients to Appropriate Care.
    Lebovics E; Torres R; Porter LK
    Am J Med; 2017 Feb; 130(2):S1-S2. PubMed ID: 28087291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Provider Attitudes toward the Use of Hepatitis C Virus-Positive Organs in Kidney Transplantation.
    Couri T; Katz J; Stoeckle K; Nugooru A; Yeh H; Chung R; Paul S
    Am J Nephrol; 2019; 50(3):168-176. PubMed ID: 31390615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis.
    Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Valencia BM; Bajis S; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J
    Lancet Gastroenterol Hepatol; 2022 May; 7(5):426-445. PubMed ID: 35303490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nationwide survey of specialist knowledge on current standard of care (Peg-IFN/RBV) and barriers of care in chronic hepatitis C patients in China.
    Wei L; Li J; Yang X; Wang G; Feng B; Hou J; Duan Z; Jia J; Ren H; Niu J; Chen X; Wang FS; Shang J; Bo Q; Li R; Liu Y; Zhuang H
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1995-2003. PubMed ID: 27043040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
    Rogal SS; McCarthy R; Reid A; Rodriguez KL; Calgaro L; Patel K; Daley M; Jonassaint NL; Zickmund SL
    Dig Dis Sci; 2017 Aug; 62(8):1933-1943. PubMed ID: 28523579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver Health Literacy and Health Status Among Adults With Hepatitis C: Implications for the Nursing Profession as Part of the 2030 Global Elimination Goal.
    Lin YC; Chiu WN; Chang TS; Huang TJ; Chen MY
    J Nurs Scholarsh; 2020 Mar; 52(2):128-135. PubMed ID: 31750620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pediatric Hepatitis C Quality Improvement Project Improves Healthcare Access.
    Vallabhan MK; Castillo R; Roldan P; Rhoades N; Kong AS; Jimenez EY
    J Pediatr Gastroenterol Nutr; 2023 Mar; 76(3):371-378. PubMed ID: 36728827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.